NEW YORK, Sept. 11, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Analysis of Venture Capital Investment Trends in the North American Healthcare Industry
The study provides insight into VC transactions that have taken place across all sectors and all regions across the globe and compares it with the North American healthcare industry. Sectors and regions that have received the maximum number and value of transactions are highlighted. Outlooks for key regions are also presented. Some of the key factors that are expected to impact investments in the next 12 to 18 months, such as regulatory changes, have also been covered. An attractiveness index to measure the VC attractiveness to fund the healthcare industry across various healthcare segments has been computed in this study.
VC Investments in North American Healthcare
•Since 2006, both the volume and the value of VC investments have decreased, but the decrease in value was considerably high. There is a clear trend showing the increase in low value deals and a good reduction in the number of high value deals.
•The early stage investments have decreased compared to late-stage funding. Attractive Regions A majority of the deals were made on the West Coast, including in Alaska, California, Hawaii, Oregon, and Washington. Attractive Segments Healthcare equipment, biotechnology, and pharmaceuticals are the leading segments that received investments both in terms of value and volume between 2006 and 2011.
•With the doors of IPO almost shut for the venture capital investors, they are now looking at new routes for exits.
•With the increase of strategic investments and corporate venturing in the pharmaceuticals and biotechnology segments, mergers and acquisitions and strategic buyouts have become attractive exit options. Venture Capital Investment Attractiveness Index The index compares the segment-wise attractiveness for venture capital investments in the North American healthcare industry.
•Growth Capital/Private Equity: Private placement transaction in which an investment is made in a mature stage or middle-market stage company with the purpose of aiding its growth.
•Venture Capital (VC): Private placement transactions that involve an investment in an incubation or start-up, early, mid, late, or emerging stage company.
•Biotechnology: Companies primarily engaged in the research, development, manufacture, and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases.
•Healthcare (HC) Technology: Companies providing information technology services primarily to the healthcare providers. Includes companies providing application, systems, and/or data processing software, Internet-based tools, and IT consulting services to doctors, hospitals, or businesses operating primarily in the healthcare sector.
•Healthcare (HC) Equipment: Manufacturers of healthcare equipment and devices. Includes medical instruments, drug delivery systems, cardiovascular and orthopedic devices, and diagnostic equipment.
•Life Sciences: Companies enabling the drug discovery, development, and production continuum by providing analytical tools, instruments, consumables and supplies, clinical trial services, and contract research services.
•Pharmaceuticals: Companies engaged in the research, development, or production of pharmaceuticals.
•Healthcare (HC) Providers and Services: Providers of patient healthcare services. Includes dialysis centers, lab testing services, and pharmacy management services. Also includes companies providing business support services to healthcare providers, such as clerical support services, collection agency services, staffing services, and outsourced sales and marketing services.
•Factors driving the venture capital investments in healthcare in North America.
•Risks involved with investing in this technology intensive industry.
•Countries that have the most congenial environment for investments.
•Preferred sectors/segments/sub-segments for investments.
•Outlook for emerging opportunities in the North American healthcare industry.
•Exit strategies followed by investors.
Key Terms Used in the Study
North American Healthcare Industry
External Challenges: Drivers and Restraints—Total Market
Historical Trends of Global VC Investments by Region and Industry
Historical Trends of VC Investments in the North American Healthcare Industry
Attractiveness Index for VC Investments in the North American Healthcare Industry
Outlook—Trends/Events Investors Need to Watch Out For
To order this report:
Investment_Banking Industry: Analysis of Venture Capital Investment Trends in the North American Healthcare Industry
Intl: +1 805-652-2626